1. Home
  2. MNOV vs CATO Comparison

MNOV vs CATO Comparison

Compare MNOV & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • CATO
  • Stock Information
  • Founded
  • MNOV 2000
  • CATO 1946
  • Country
  • MNOV United States
  • CATO United States
  • Employees
  • MNOV N/A
  • CATO N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • CATO Clothing/Shoe/Accessory Stores
  • Sector
  • MNOV Health Care
  • CATO Consumer Discretionary
  • Exchange
  • MNOV Nasdaq
  • CATO Nasdaq
  • Market Cap
  • MNOV 65.7M
  • CATO 57.6M
  • IPO Year
  • MNOV 2005
  • CATO N/A
  • Fundamental
  • Price
  • MNOV $1.22
  • CATO $4.64
  • Analyst Decision
  • MNOV Strong Buy
  • CATO
  • Analyst Count
  • MNOV 2
  • CATO 0
  • Target Price
  • MNOV $7.00
  • CATO N/A
  • AVG Volume (30 Days)
  • MNOV 64.9K
  • CATO 204.6K
  • Earning Date
  • MNOV 11-12-2025
  • CATO 08-21-2025
  • Dividend Yield
  • MNOV N/A
  • CATO N/A
  • EPS Growth
  • MNOV N/A
  • CATO N/A
  • EPS
  • MNOV N/A
  • CATO N/A
  • Revenue
  • MNOV $134,599.00
  • CATO $650,830,000.00
  • Revenue This Year
  • MNOV N/A
  • CATO N/A
  • Revenue Next Year
  • MNOV N/A
  • CATO N/A
  • P/E Ratio
  • MNOV N/A
  • CATO N/A
  • Revenue Growth
  • MNOV N/A
  • CATO N/A
  • 52 Week Low
  • MNOV $1.13
  • CATO $2.19
  • 52 Week High
  • MNOV $2.55
  • CATO $6.70
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 37.71
  • CATO 68.86
  • Support Level
  • MNOV $1.25
  • CATO $3.84
  • Resistance Level
  • MNOV $1.38
  • CATO $4.73
  • Average True Range (ATR)
  • MNOV 0.04
  • CATO 0.26
  • MACD
  • MNOV -0.01
  • CATO -0.00
  • Stochastic Oscillator
  • MNOV 0.00
  • CATO 73.33

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.

About CATO Cato Corporation (The)

The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.

Share on Social Networks: